Industry News
Pharmaceutical Industry News
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.
Fake Ozempic Found in U.S., F.D.A. Warns
The agency and Novo Nordisk, the company that makes Ozempic, are testing the seized medications to determine what is in them.
What to Know About Antibiotics and Antimicrobial Resistance
It’s antibiotic season. Brush up on how you should use them — and when to avoid them.
Can Ozempic and Weight Loss Drugs Treat Other Diseases?
Scientists are exploring whether the new diabetes and weight-loss drugs could also treat addiction, kidney disease and more.
We Know How to Put People on Ozempic. Do We Know How to Get Them Off It?
How informed consent about long-term prescriptions can be improved.
Possible Ways to Ease Drug Shortages
Lawmakers, U.S. officials and industry experts have offered measures to try to shore up the generic drug market.
Behind the Shortage Keeping Cancer Patients From Chemo
Key drugs have been in scarce supply, revealing a deep crisis in the generic drug industry.
New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatments
Researchers in developing countries are trying to find treatments for conditions that affect the poorest people. But the system is stacked against their therapies.
Monsanto Should Pay $857 Million in PCB Case, Jury Finds
Students and parent volunteers from a school in Washington State said in a lawsuit that they had become sick after being exposed to chemicals known as PCBs that had dripped from light fixtures.
What to Know About the Effects of Ketamine
Matthew Perry’s death was attributed to the effects of high levels of the anesthetic drug, which is increasingly used to treat depression.
Doctors on the Use of Medical Cannabis
Two physicians respond to a front-page article. Also: The children in Gaza; reviving local news; a divide in texting.
Hair-Loss TikTok Offers Community, and Dubious Recommendations
Hair-loss influencers on TikTok say they are destigmatizing a common insecurity. Critics say they are cashing in on a vulnerable audience.
Drugs like Wegovy Can Fix Teenage Obesity, but Young People Don’t Get Them
Pediatricians are hesitating to prescribe medicines like Wegovy, citing their newness and uncertainties around them.
Do Sleeping Pills Work? A Guide to Insomnia Drugs and Their Risks
A guide to the different types of medications for treating insomnia, their risks and when experts recommend using them.
F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
Why We’re Stuck in a Constant Cycle of Drug Shortages
A few simple solutions could save lives and ease the struggles of countless Americans.
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Up
Juries recently awarded plaintiffs more than $2 billion in damages tied to Roundup, the weedkiller that has been linked to cancer. Bayer is fighting back.
CVS Says It Will Change the Way Its Pharmacies Are Paid
The drugstore chain is introducing a model that will compensate pharmacies based on how much they paid for a drug, as well as a set markup and service fee.
¿Un medicamento para que tu perro viva más?
Los fármacos para la longevidad de nuestros compañeros caninos están cada vez más cerca de hacerse realidad. También plantean interrogantes.